Innovative and Articulate: Protagenic Therapeutics Announces Pricing of Private Placement for $12.75 Million
Protagenic Therapeutics Announces Purchase Agreement for 1,948,295 Shares of Common Stock New York, NY / ACCESSWIRE / October 29, 2024 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) Biopharmaceutical Innovation Protagenic Therapeutics, a leader in biopharmaceutical innovation, has recently made a significant announcement regarding a purchase agreement for the sale of an aggregate of 1,948,295 shares of common…